Mev Dominguez-Valentin, PhD is a Project Group Leader at the Department of Tumor Biology of the Institute for Cancer Research from Oslo University Hospital (Norway). She is the Principal Investigator of the largest prospective Lynch Syndrome database (PLSD) aiming to facilitate personalized precision medicine for Lynch syndrome. Her main research areas include Lynch syndrome and the large prospective observational studies that have recently increased understanding of the effectiveness of colonoscopy surveillance and the heterogeneity of cancer risk between genotypes. She is also interested in implementing the advances in diagnosis of hereditary cancer susceptibility and applying these insights to clinical practice in Latin America.
In her lecture this year, Dr. Dominguez-Valentin will give an update on the epidemiology research of Lynch syndrome based on the PLSD data.

Sir Harpal Kumar

GRAIL Europe

Prof. Phil Quirke

University of Leeds, UK

Prof. Sir John Burn

Newcastle University, UK

Dr. Mev Dominguez-Valentin

Oslo University Hospital, Norway

Prof. Dr. Silvia Stacchiotti

Fondazione IRCCS INT, Italy

Prof. Yann Parc

Saint-Antoine Hospital, France

Dr. Neil Ryan

Edinburgh University, UK

Caroline Kahn

Copenhagen University Hospital, Denmark

Prof. Andrew T. Chan

Harvard Medical School, USA

Prof. Ann-Sofie Backman

Karolinska Institute, Sweden

Prof. Matthias Kloor

Heidelberg University Hospital, Germany

Prof. Richard Anderson

University of Edinburgh, UK

Programme

All About the 8th Annual EHTG Meeting

We are delighted to invite you to the 8th annual EHTG meeting which will take place on the 27th and 28th of September 2024 – online!

The time scheduled in the programme is referring to CET (Central European Time).

This template is made with by Colorlib
+